LACK OF PHARMACOKINETIC INFLUENCE ON LEVODOPA BY BROMOCRIPTINE

被引：12

作者：

BENTUEFERRER, D ^{[1
]}

ALLAIN, H ^{[1
]}

REYMANN, JM ^{[1
]}

SABOURAUD, O ^{[1
]}

VANDENDRIESSCHE, J ^{[1
]}

机构：

[1] HOP PONTCHAILLOU,SERV NEUROL,RENNES,FRANCE

来源：

CLINICAL NEUROPHARMACOLOGY | 1988年 / 11卷 / 01期

关键词：

D O I：

10.1097/00002826-198802000-00009

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：83 / 86

页数：4

共 14 条

[1] A POSSIBLE MOLECULAR MECHANISM FOR THE ANTIPARKINSONIAN ACTION OF BROMOCRIPTINE IN COMBINATION WITH LEVODOPA [J].

GOLDSTEIN, M ;

LIEBERMAN, A ;

MELLER, E .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1985, 6 (11) :436-437

[2] BROMOCRIPTINE IN THE MANAGEMENT OF END OF DOSE DETERIORATION IN PARKINSONS-DISEASE [J].

GRIMES, JD ;

KING, DB ;

KOFMAN, OS ;

MOLINANEGRO, P ;

WILSON, AF ;

BOUCHARD, S .

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (04) :452-456

[3]

GRON U, 1977, ACTA NEUROL SCAND, V56, P269

[4]

HOEHN MMM, 1985, ACTA NEUROL SCAND, V71, P97

[5]

HOEHN MMM, 1985, NEUROLOGY, V35, P199

[6] HYPOTHESIS - BROMOCRIPTINE LACKS INTRINSIC DOPAMINE RECEPTOR STIMULATING PROPERTIES [J].

JACKSON, DM ;

JENKINS, OF .

JOURNAL OF NEURAL TRANSMISSION, 1985, 62 (3-4) :219-230

[7] BROMOCRIPTINE POTENTIATES THE BEHAVIORAL-EFFECTS OF DIRECTLY AND INDIRECTLY ACTING DOPAMINE RECEPTOR AGONISTS IN MICE [J].

JENKINS, OF ;

JACKSON, DM .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1985, 331 (01) :7-11

[8]

LIEBERMAN AN, 1985, PHARMACOL REV, V37, P217

[9] SIMULTANEOUS DETERMINATION OF CARBIDOPA, LEVODOPA AND 3,4-DIHYDROXYPHENYLACETIC ACID USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION [J].

NISSINEN, E ;

TASKINEN, J .

JOURNAL OF CHROMATOGRAPHY, 1982, 231 (02) :459-462

[10] COMBINED BROMOCRIPTINE-LEVODOPA THERAPY EARLY IN PARKINSONS-DISEASE [J].

RINNE, UK .

NEUROLOGY, 1985, 35 (08) :1196-1198

← 1 2 →